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Spatially defined chromosome regions,
termed variable chromatin modules,
exhibit coordinated chromatin state
changes across cis-regulatory elements.
Within these modules, genetic changes
distal from the regulatory element itself
can induce variation in chromatin
patterns between individuals.
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Chromatin state variation at gene regulatory ele-
ments is abundant across individuals, yet we under-
stand little about the genetic basis of this variability.
Here, we profiled several histone modifications, the
transcription factor (TF) PU.1, RNA polymerase II,
and gene expression in lymphoblastoid cell lines
from 47 whole-genome sequenced individuals. We
observed that distinct cis-regulatory elements exhibit
coordinated chromatin variation across individuals
in the form of variable chromatin modules (VCMs)
at sub-Mb scale. VCMs were associated with thou-
sands of genes and preferentially cluster within chro-
mosomal contact domains. Wemapped strong prox-
imal and weak, yet more ubiquitous, distal-acting
chromatin quantitative trait loci (cQTL) that frequently
explain this variation. cQTLs were associated with
molecular activity at clusters of cis-regulatory ele-
ments andmappedpreferentially within TF-bound re-
gions. We propose that local, sequence-independent
chromatin variation emerges as a result of genetic
perturbations in cooperative interactions between
cis-regulatory elements that are located within the
same genomic domain.INTRODUCTION
Understanding the genetic contribution and molecular paths to-
ward complex traits is one of the key outstanding challenges
in biology. Genome-wide studies revealed that most common
disease-associated genetic variants fall into gene regulatory se-
quences (Manolio, 2010; Maurano et al., 2012; Nica et al., 2010;Nicolae et al., 2010) and affect transcriptional programs in
disease-implicated cell types (Fairfax et al., 2012; Grundberg
et al., 2012). Evolutionary studies have further uncovered several
instances of gene regulatory changes that are causally impli-
cated in complex phenotypes (Wray, 2007). These changes are
thought to originate mostly from variation in TF-DNA interac-
tions, which are well known to mediate the spatiotemporal
control of gene expression programs (Spitz and Furlong, 2012).
Understanding the extent of, and the mechanisms underlying,
TF DNA binding variation is therefore key to elucidate the molec-
ular determinants of complex phenotypes. Small-scale popula-
tion- and family-based studies have shown that 5%–25% of
TF-DNA binding events exhibit intra- and inter-individual binding
variation (Kasowski et al., 2010, 2013; Kilpinen et al., 2013;
McVicker et al., 2013; Reddy et al., 2012). These studies, as
well as those examining TF-DNA binding divergence among
mammalian species (reviewed in Villar et al. [2014]) showed
that only a minority of this variation could be attributed to genetic
differences within TF-bound sequences.
So far, few mechanisms have been proposed to clarify this
phenomenon, and these are mostly centered on changes in
either the local DNA structure or in collaborative interactions be-
tween co-bound TFs at cis-regulatory elements (Albert and Kru-
glyak, 2015; Heinz et al., 2013; Karczewski et al., 2011; Kilpinen
et al., 2013; Stefflova et al., 2013). Recently, others and we have
observed that several chromatin state components exhibit a
strong degree of coordinated allelic variation that extends over
several thousands of base pairs (Kilpinen et al., 2013; McVicker
et al., 2013). This observation suggests that variation in TF-DNA
binding might be conditioned on the state of other cis-regulatory
elements, but a general description of this effect has so far been
hampered due to sparseness of allelic markers.
Here, we measured ChIP-seq-based, population-level histone
modification (HM) and TF enrichment patterns. Specifically, we
mapped the regulatory TF PU.1, the second largest subunit of
RNA polymerase II (RPB2), and three well-studied HMs oftenCell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc. 1039
Figure 1. Genome-wideAssociationsamong
Molecular Phenotypes
(A) Inter-individual association between the read
depth at H3K27ac and H3K4me1 ChIP-seq peaks
on chromosome 21 (26,000,000–28,000,000). The
pairwise association strength (Pearson’s p value)
is color coded and ranges from blue (p = 1) to red
(p < 1e-10). Chromosomal contact domains (Rao
et al., 2014) are shown with black boxes. See Fig-
ure S1H for molecular associations in this region
based on other marks.
(B) Significant associations between molecular
phenotypes in a 1 Mb window on chr21
(27,000,000–28,000,000). Circles indicate variable
(filled) or non-variable (open) enrichment of molec-
ular marks (i.e., ChIP-seq peaks or gene expres-
sion). Lines connecting filled circles represent
significant associations between molecular pheno-
types (FDR 0.1%).
(C) Selected individuals with either low (NA06986
and NA11992) or high (NA06985 and NA12489)
enrichment of molecular marks around the APP
gene locus.
(D) Distance distribution between coordinated mo-
lecular phenotypes.
(E) Annotation of cis-regulatory elements with co-
ordinated enrichment of molecular marks into pu-
tative enhancers (E) and promoters (P).
See also Figures S1, S2, and S3.observed at enhancers and promoters (H3K4me1, H3K4me3,
and H3K27ac) in lymphoblastoid cell lines (LCLs) derived from
47 unrelated European individuals whose genomes were seq-
uenced in the frame of the 1000 Genomes Project (Abecasis
et al., 2010). In addition, we profiled gene expression using
mRNA sequencing in 46 LCLs. Our results provide unique in-
sights into the mechanisms underlying variation in molecular
activity at cis-regulatory elements, revealing that most of this
variation results from alterations in the modular organization of
the human genome.
RESULTS
Population-Level Variation in Molecular Activity at
cis-Regulatory Elements
Toassess theextentofquantitativecoordination in inter-individual
chromatin variation at putative cis-regulatory elements, we per-1040 Cell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc.formed an association analysis between
molecular phenotypes, with ‘‘molecular
phenotype’’ being here defined as the
normalized and covariate-corrected read
depth of a histone-modified and TF-bound
region, respectively. Specifically, we esti-
mated the correlation levels between all
distinct TF-TF, HM-HM, and TF-HM com-
binations in 1 Mb cis windows (Figure 1A).
We tested a total of 29million associations
between any two molecular phenotypes
and estimated for each association pair
the enrichment of low p values using p1
statistics (Storey and Tibshirani, 2003). Estimates of p1 ranged
from 2.5% for PU.1-H3K4me3 to 11% for H3K4me1-H3K27ac
(FigureS1A), indicating extensive quantitative coordination inmo-
lecular activity levels between/at cis-regulatory elements. More-
over, molecular coordination decayed quickly with increasing
genomic distance and was 20-fold more enriched between prox-
imal cis-regulatory elements (<10 kb) than between any two cis-
regulatory elements that were separated by 500 kb or more
(Figure S1B).
Overall, we detected 79,411 statistically significant, mostly
positive (>99%) associations (at genome-wide correction) across
all molecular association tests (Pearson rmean = 0.70, FDR 0.1%)
(Figures 1B, 1C, S1C, and S1D), involving on average 20% of
all studied TF-bound/HM-enriched regions (Figure S1E). The his-
tonemarkH3K27ac exhibited the highest number and proportion
of significant associations with other phenotypes (Figures S1E
and S1F), suggesting that this molecular phenotype is most
Figure 2. Variable Chromatin Modules
(A) Molecularmark composition of variable chromatin modules (VCMs). Black bars (top) indicate the percentage of VCMswith specific combinations of molecular
marks (bottom). Inset shows the percentage of VCMs with a specific molecular mark.
(B) Coordination of molecular activity within VCMs. The heatmap illustrates for 47 individuals (rows) the normalized signal of molecular phenotypes (columns) that
belong to the VCM spanning the APP gene locus (as shown in Figures 1B and 1C). (Right column) The first principal component summarizes the majority (71%) of
molecular variation within this VCM.
(C) Percentage of molecular variation within VCMs that is explained by the first and second principal components. VCMswere divided according to the number of
cis-regulatory elements (domains). VCMs withR20 domains were grouped.
(D) Enrichment of covariable cis-regulatory elements within chromosomal contact domains (Rao et al., 2014). (Red) Covariable cis-regulatory elements; (blue)
random pairs of cis-regulatory elements. The probability indicates whether two covariable cis-regulatory elements are embedded within the same contact
domain as opposed to two distinct contact domains.
(E) Co-associations of TF-TF pairs at non-overlapping, covariable cis-regulatory elements. Positive and negative odds ratios indicate significant enrichment/
depletion of TF-TF pairs (p < 0.05 after Bonferroni correction).
See also Figures S2 and S3.sensitive to coordinated chromatin state perturbations. As ex-
pected, the TFs PU.1 and RPB2 were preferentially associated
with enhancer- (H3K27ac/H3K4me1 for PU.1) and promoter-
marking HMs (H3K27ac/H3K4me3 for RPB2), respectively (Fig-
ure S1G). Except for RPB2-H3K4me3, the majority of all mo-
lecular associations were identified between non-overlapping
cis-regulatory elements (Figure S2A), which exhibit a log-normal
distance distribution that preferentially centered around 45 kb
(95% confidence interval [CI]: 7–308 kb) (Figures 1D and S2B).
The molecular association strength between covariable cis-reg-
ulatory elements decayed significantly with increasing distance
(r=0.19, p< 2.2e-16, FigureS2C).Overall, 25%of allmolecular
associations were found between promoters and enhancers
(>5 kb from transcription start site [TSS]), 25%within or between
promoters, and 50% within or between putative enhancers (Fig-
ure 1E). These results suggest extensive molecular coupling be-
tween cis-regulatory elements and a strong degree of chromatin
variation at enhancer-like regions.
The previous results indicate that chromatin state variation
might reflect high-order genomic interactions. Using simple
graph-based methods, we could map individual molecularassociations into 14,559 distinct ‘‘variable chromatin modules
(VCMs)’’ that are composed of 25,417 distinct cis-regulatory
elements (see Figures 1B, 1C, and S3A–S3C for examples). The
median size of a single VCMwas 4.2 kb, and all molecular pheno-
types contained within VCMs together covered 5% (161 Mb) of
thehumangenome.Althoughonly 25%ofVCMswere composed
of multiple cis-regulatory elements (Figure S3D), these ‘‘multi-
VCMs’’ captured (1) the vast majority (78%) of molecular associ-
ations (Figure S3E), (2) weremore likely to contain promoter- and
enhancer-marking chromatinmarks (FigureS3F), and (3) covered
more DNA sequence (median size: 70 kb; Figure S3G).
The majority of VCMs (56%) were exclusively composed of
enhancer-marking signals (i.e., H3K4me1-PU.1, H3K4me1-
H3K27ac, and H3K4me1-H3K27ac-PU.1) (Figure 2A), indicating
that putative enhancers constitute the largest part of the var-
iable epigenome in a single human population, consistent with
comparative epigenomic studies across mammalian species
(Villar et al., 2015).
To examine the extent of molecular coordination within VCMs,
we tested whether the activity state of a VCM can be represented
by a single quantitative phenotype, rather than by individualCell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc. 1041
molecular phenotypes that define a VCM. We applied principal
component (PC) analysis and extracted the first and second PC
for each VCM (Figure 2B). We found that the first PC already ex-
plains, onaverage, 79%of thevariability that is observedbetween
molecular phenotypes of the same VCM (Figure 2C), suggesting
that molecular activity is strongly coordinated within VCMs.
This high degree of molecular coordination within VCMs
implies a higher-order chromatin organization, consistent with
the now well-accepted notion that mammalian genomes are
spatially arranged in distinct chromosomal contact domains
(Dixon et al., 2012; Rao et al., 2014). To test this hypothesis,
we analyzed published, high-resolution, and genome-wide chro-
matin conformation data from a human lymphoblastoid cell
line (Rao et al., 2014) and found that cis-regulatory elements
with coordinated chromatin state variation were more pre-
ferentially embedded within the same chromosomal contact
domain (odds ratio = 14.9, p = 2.2e-16, logistic regression) (Fig-
ure 2D; see Figures 1A and S1H-S1I for examples). We also
observed that cis-regulatory elements of the same VCM ex-
hibited more frequently allelic chromatin biases along the same
haplotype (OR = 1.3, p = 4.9e-5, logistic regression), further
indicating that VCM define a regulatory unit. Moreover, analysis
of genome-wide TF-DNA binding data of the architectural
proteins CTCF and cohesin (RAD21/SMC3) (Ong and Corces,
2014) revealed a significant enrichment at cis-regulatory ele-
ments that participate in long-range (>300–500 kb) molecular
associations (Figures S2D–S2F). Together, these results support
our hypothesis that VCMs represent a fine-grained, modular
architecture of the variable human epigenome.
Next, we aimed to elucidate mechanisms that may be respon-
sible for the emergence of VCMs. Here, we hypothesized that
modular chromatin state dynamics may not only be driven by
short-range cooperative TF-TF interactions, as shown earlier
(Karczewski et al., 2011; Kasowski et al., 2010; Kilpinen et al.,
2013; Zheng et al., 2010), but also by interactions that act over
long genomic distances and across cis-regulatory elements.
To test this hypothesis, we investigated whether particular
TF-TF pairs exhibited preferential enrichments at pairs of cis-
regulatory elements that are part of the same VCM using ex-
perimentally defined TF-DNA binding data (ENCODE Project
Consortium, 2012). This analysis revealed 204 putative cooper-
ative TF-TF pairs that are preferentially enriched at VCM-defined
cis-regulatory elements (OR = 1.1-3.2; p < 0.05 after Bonferroni
correction; Fisher’s exact test) (Figure 2E). For example, NFKB
emerged as the most cooperative TF among all tested factors
and was preferentially associated with well-known immunity-
associated TFs (e.g., STAT3, BCL11A, BATF, and PU.1). Thus,
our results suggest that modular chromatin dynamics occur
within spatially organized domains of the genome and are likely,
in part, mediated by long-range cooperative interactions be-
tween TFs that determine themolecular identity of a lymphoblas-
toid cell (Zhou et al., 2015).
Chromatin Variation Reflects Inter-Individual Variation
in Gene Expression
To assess the functional impact of inter-individual chromatin
state variation, we analyzed associations in cis between molec-
ular phenotypes at cis-regulatory elements and gene expression1042 Cell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc.(TSS ± 1 Mb). This analysis resulted in significant associations
for 4,568 (22%) genes at a FDR of 0.1% (Figure S3H and see
Figures 3A, S3I, and S3J for examples). The vast majority
(99%) of chromatin-gene associations were positive (i.e., higher
gene expression levels correlated with stronger chromatin sig-
nals) (Figure S3K), explained about half of the variation in
gene expression (Figure S3L), and correlated independently
with multiple molecular events at cis-regulatory elements. Two-
thirds of all gene-associated cis-regulatory elements mapped
outside of promoters (TSS ± 2.5 kb) and thus likely pinpoint to
putative enhancer-gene interactions (Figures 3B and 3C). We
further measured allelic expression effects within individuals
and observed that, consistent with coordinated allelic chromatin
signals, they are more concordant with allelic chromatin states
at gene-associated regions than at random regions (OR = 1.9,
p = 2e-10, logistic regression). Together, these results provide
genome-wide evidence that population-level variation in chro-
matin states has functional consequences and that it is a
potential approach to identify the gene targets of putative cis-
regulatory elements.
We also observed that VCM states (as defined by the first PC)
were associated with 3,580 genes in cis (TSS± 1Mb; FDR 0.1%).
This analysis has further allowed us to uncover that only 5%
of ‘‘enhancer VCMs’’ (H3K27ac-H3K4me1-PU.1) varied along
with nearby genes despite representing the most abundant
class of VCMs. In strong contrast, variable promoter (H3K27ac-
H3K4me3-RPB2) and promoter-enhancer (H3K27ac-H3K4me3-
H3K4me1-RPB2-PU.1) VCMs correlated with gene expression
in up to 80% of the cases (Figure 3D). Moreover, 23% of all
gene-associated VCMs correlated with the expression levels of
multiple genes (Figure S3M), suggesting that these VCMs contain
cis-regulatory elements that are potentially shared across genes.
We also found that VCMs with several cis-regulatory elements
were more likely to reflect variable gene expression (Spearman’s
r = 0.91, p = 1.8e-8) (Figure 3E), suggesting that both the type
(promoter/enhancer) and number of variable cis-regulatory ele-
ments are key determinants underlying the transcriptional state
change of a gene.
We next assessed whether VCMs were located nearby spe-
cific sets of genes and found that VCMs embedding several
cis-regulatory elements were highly enriched in immunity-related
processes and pathways (Tables S2A and S2B), consistent
with the biological nature of lymphoblastoid cells. Functional
analysis of chromatin-associated genes further supported a
strong enrichment of VCMs in immunity-related processes
(Table S2C).
Genetic Control of Chromatin State and Gene
Expression Variation
To identify potential mechanisms that explain variation in TF-
DNA binding, HMs, VCM states, and gene expression, we
mapped quantitative trait loci (QTLs) for all studied molecular
phenotypes independently in a 500 kb cis-window around
the center of a candidate cis-regulatory element (or TSS). We
detected between 315 and 1,432 significant chromatin QTLs
(cQTLs, i.e., tfQTLs and hmQTLs) and eQTLs at 10% FDR. This
corresponds from 1.1% (H3K4me1) to 2.9% (mRNA) of the
studied regions and explained 40% of their variability (Figures
Figure 3. Association between Chromatin State and Gene Expression Variation
(A) Inter-individual co-variation between mRNA levels and H3K27ac enrichment signals at cis-regulatory elements on chromosome 21 (26,000,000–28,000,000).
The pairwise association strength (Pearson’s p value) is color coded and ranges from blue (p = 1) to red (p < 1e-10) (legend, see Figure 1A). Chromosomal contact
domains (Rao et al., 2014) are shown with black boxes.
(B) Distance distribution in log-space between the transcription start site (TSS) and cis-regulatory elements with expression-linked molecular phenotypes.
(C) Classification of gene-expression-linked cis-regulatory elements with molecular marks into putative enhancers and promoters (TSS ± 5 kb).
(D) Percentage of VCMs with gene expression associations (using the first principal component for VCM states) stratified by molecular mark compositions.
(E) Percentage of VCMs associated with gene expression stratified by VCM size (i.e., number of cis-regulatory elements that belong to a VCM).
See also Figure S3.4 and S4). Of note, the number of discovered QTLs significantly
increased upon reduction of the cis-window size yet at the
expense of excluding distal effects (Figures S4A–S4C). Indels
and structural variants were significantly enriched among cQTLs
(Figure S5A), consistent with previous studies (Kasowski et al.,
2010; Schlattl et al., 2011). We further used allele-specific anal-
ysis to validate cQTLs on a genome-wide scale (Lappalainen
et al., 2013). We observed more significant allelic chromatin
biases at cQTLs as compared to control sites (Figure 4C) and
higher proportions of allelic chromatin biases at strong cQTLs
(Figure 4D), thus supporting our cQTL inference. In addition, we
mapped 1,173 vcmQTLs (8.1%) using the first PC as a quantita-
tive trait (comprising 4,187 individualmolecular phenotypes) and,
surprisingly, none using the secondPCdespite observing a small
enrichment of low p values (Figure S4G). This suggests that the
firstVCMstate captures theprimarygenetic contributions toward
VCM activity. Overall, we found that all molecular phenotypes
and, in particular, VCMs are affected by common genetic vari-
ants, supporting the hypothesis that a substantial proportion of
coordinated chromatin state variation is driven by cis-acting ge-
netic variation.We further assessed the genomic location of cQTLs by
measuring their distance relative to TF-targeted and histone-
modified regions. We found that the resulting distances exhibit
bimodal log-normal distributions, with the first mode centering
very close to the mid-point of TF-bound sites (medians between
10 and 40 bp) and relatively close to the mid-point of HM regions
(medians between 230 and 300 bp), and the second mode being
located distally from its respective target region (medians be-
tween 20 and 30 kb) (Figure 4A). In contrast, when we tested
the distance relative to the closest TSS (Figure S5B), the log-
normal bimodal signal completely disappeared, suggesting
that the first mode derives from cQTLs falling within their respec-
tively TF or HM-enriched target regions (Figures S5C and S5D).
Although the proximally mapping cQTLs exhibited signifi-
cantly stronger effect sizes than cQTLs located outside of their
target elements (Figure 4B), they constituted only a minority
(25%) of all cQTLs. For example, we found that only 33% of
PU.1 QTLs mapped inside of PU.1-bound regions, demon-
strating that TF binding is strongly influenced by distal genetic
effects. This complexity indicates that, like gene expression,
sequence-specific TF-DNA binding can be considered as aCell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc. 1043
Figure 4. Genetic Control of Chromatin
State Variation
(A and B) Quantitative trait locus (QTL) mapping for
TF-DNA binding and HMs. (A) Bimodal distance
distribution (in log10-space) between cQTLs and
their associated cis-regulatory elements (FDR
10%). (B) Relationship between cQTL strength and
genomic architecture. Boxplots demonstrate ge-
netic association strength (log10 p value) for QTL
variants that map inside (red) and outside (blue) of
their target TF-bound/histone-modified regions.
Percentages refer to the proportion of cQTLs that
fall inside and outside of their target regions.
(C and D) Allele-specific (AS) signals at cQTLs. (C)
AS effect strength (log10 binomial p value) at
heterozygous QTL (blue) and non-QTL variants
(red). (D) Estimated frequency of AS effects (using
p1 statistics) at heterozygous variants as a function
of cQTL strength (log10 p value). For example,
83% of the heterozygous variants exhibit AS sig-
nals in PU.1 binding when considering genetic
variants that are associated with PU.1 binding
variation at p < 106.
See also Figures S4 and S5.complex trait, similar to other molecular and organismal traits.
Moreover, we found that distally acting cQTLs exhibited dis-
tances that matched the extent of coordination within VCMs,
further supporting interactions across regions in the genome.
These observations suggest a dual mode of action for cQTLs:
strong cQTLs directly perturbing the proximal interactions that
form the local chromatin signal and more abundant yet weaker
cis-acting cQTLs exerting their effects over large distances (up
to hundreds of kilobases). The latter process likely involves
several intermediate molecular processes that operate within
the same VCM.
Given the high degree of quantitative coordination between
chromatin state components of the same VCM, we assessed
whether distinct molecular phenotypes were affected by the
same cQTL. We estimated that half of all cQTLs are shared
between two chromatin phenotypes, revealing a strong genetic
basis for coordinated chromatin state variation across individ-
uals (Figure 5A). In addition, we found that cQTL-eQTL sharing
ranged from a relatively moderate (24% of PU.1 QTLs were
also eQTLs) to a very high (73% of H3K4me3 QTLs were also
eQTLs) degree (Figure 5A). These results demonstrate that only
a small proportion of genetically variable TF-DNA binding events
actually lead to measurable changes in gene expression, in
line with recent TF knockdown studies carried out in LCLs
(Cusanovich et al., 2014). They also suggest that promoter
QTLs show very high specificity for genetic gene perturbations,
consistent with the enrichment of complex trait-associated
variants in cell-type-specific H3K4me3 regions (Trynka et al.,
2013).
We further characterized the width and the depth of the QTL
signal path by estimating the number of distinct molecular marks1044 Cell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc.and phenotypes that were affected by the
same cQTL and eQTL. We observed that
the majority of QTLs affect several molec-ular marks (75%) (Figuress 5B and S6A) and molecular pheno-
types of the same and/or different type (80%) (Figures 5C and
S6B). Instances of QTLs for which we did not identify cross-
talk between distinct molecular marks were of significantly lower
effect sizes (Figure S6C). In contrast, 99% of vcmQTLs were
associated with multiple molecular marks and phenotypes, sug-
gesting that they capture the deepest and widest range of ge-
netic associations across all studied epigenomic components.
Taken together, these results demonstrate that the majority of
cQTLs perturb several chromatin state components at the
same or across distinct cis-regulatory elements.
We next set out to identify which component is more likely
to initiate the genetically induced molecular cascade. To do so,
we estimated the enrichment of each QTL class being located
within particular functional elements. The underlying reasoning
was that QTLs that overlap a functional element should initially
affect that element first before their effect extends toward non-
overlapping elements that belong to the same VCM. We found
a clear enrichment signal in TF-bound regions for all types of
QTLs. For instance, H3K27ac and H3K4me1 QTLs were seven
times more likely to be located within PU.1-bound regions than
expected by chance, and vcmQTLs were nine times more en-
riched within PU.1-bound regions (Figure 5D). We independently
validated this observation by testing for enrichment of QTLs in
open chromatin regions and experimentally defined TF-bound
regions (Figures S6D and S6E). We found that vcmQTLs demon-
strated the strongest enrichment at regions that were bound by
PU.1, BATF, BCL11A, NFKB, MEF2A, and IRF4 (Figure S6E),
consistent with our observations that these TFs are specifically
enriched at variable cis-regulatory elements (Figure 2E). More-
over, cQTLs that fell within TF-bound regions exhibited stronger
Figure 5. Sharing of Genetic Associations between TF-DNA Binding, HMs, and Gene Expression
(A) Estimation of QTLs that are shared between molecular marks. For example, 81% of H3K4me3 QTLs are also associated with H3K27ac marks.
(B and C) Collateral impact of genetic variation on chromatin architecture and gene expression. (B) Percentage of tf-, hm-, and eQTLs being associated with
multiple distinct molecular marks, i.e., DNA binding (PU.1, RPB2), HM levels (H3K4me1, H3K4me3, H3K27ac), and gene expression. For example, 75% of QTLs
affect multiple marks. Triangle, genetic variant; other symbols, molecular marks. (C) Percentage of tf-, hm-, and eQTLs being associated with multiple molecular
phenotypes (i.e., TF-binding, HM levels, and gene expression). For example, 7.5% of all QTLs affect >10 molecular phenotypes. Triangle, genetic variant; other
symbols, molecular phenotypes.
(D) Enrichment of QTLs within active cis-regulatory elements. For example, vcmQTL variants map nine times more likely into PU.1-bound regions than expected
by chance.
(E) Estimation of allelic effect frequency (using p1 statistics) at heterozygous QTL variants. For example, AS effects at H3K27ac sites are 2.2-fold more likely at
PU.1 QTL variants as compared to all variants.
See also Figures S5 and S6.effect sizes than those falling outside of such regions (Fig-
ure S6F), and we observed stronger enrichment of allelic biases
at tfQTLs as compared to hmQTLs for each studied molecular
mark (Figure 5E).
We next investigated the impact of TF motif disruption and its
downstream effects onto other molecular phenotypes, using
Bayesian network modeling. We assessed all molecular associ-
ations that involve PU.1 and considered cases separately
whereby PU.1 QTL variants disrupted a PU.1 binding site. We
observed that PU.1-DNA binding variation was more likely to
be causal to variation in H3K27ac and H3K4me1 signals in cases
in which the PU.1 motif was disrupted as compared to cases in
which the PU.1 QTL mapped elsewhere in the genome (Fig-
ure S6G). Thus, these results indicate that sequence-specific
TF-DNA interactions are an important driving force behind in-
ter-individual chromatin state variation.The previous sections demonstrated that genetic perturbation
of a few molecular phenotypes can be causal to changes in
downstream molecular phenotypes, thus providing a potential
explanation as to why most variation in chromatin state is likely
independent of proximal sequence changes. VCMs provide the
conceptual framework to test the hypothesis of a few molecular
phenotypes causing collateral changes to chromatin states
across cis-regulatory elements. We therefore performed associ-
ation analysis of vcmQTL variants with every molecular pheno-
type of the corresponding VCMand observed strong association
signalswith individualmolecular phenotypes (Figures 6Aand6B).
Moreover, we observed that the average QTL strength for
individual molecular phenotypes scales significantly with the
strength of vcmQTLs (r = 0.91, p < 2.2e-16) yet one order of
magnitude weaker (Figure S6H). The latter observation sug-
gests one or more of the following possibilities: (1) higher-orderCell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc. 1045
Figure 6. Propagation of Genetic Signals through Molecular Phenotypes
(A) Distribution of log-transformed association p values for vcmQTL variants and VCM-defining molecular phenotypes.
(B and C) Genetic variation exhibits direct and indirect effects on chromatin architecture. (B) Significant association between the SNP rs6537048 and the state of
VCM vcm10018 (chr4:142,224,793–142,570,395) upstream of IL15. See Figure S1I for molecular associations in this region based on all marks. Boxplot shows
the PCA-derived vcm10018 activity level split by genotype of the SNP rs6537048. Molecular phenotypes within vcm10018 are themselves associated with
rs6537048. Molecular association structure is shown together with rs6537048 genotype-averaged TF DNA binding and HM signals. Nodes define individual
marks for specific molecular phenotypes (i.e., TF binding and HM) and gray lines depict significant associations between these molecular phenotypes. (C) VCM
associations are contrasted against the association strength of the same vcmQTL variant with individual molecular phenotypes (i.e., TF-DNA binding and HM).
The molecular association structure within VCMs is used to define three layers of molecular events (entry, first degree, and second degree, see main text).
Boxplots show the ratio of genetic association strength between VCMs and the average of individual molecular phenotypes (i.e., log10 PVCM/PTF/HM).
(D) Inference of causal relationships between VCM state and gene expression using Bayesian causality modeling. The frequency of the most likely model is
shown.
(E) Enrichment of cQTLs and eQTLs in complex disease susceptibility variants by trait class. The gray bars signify 95% CI.
See also Figure S6.chromatin statesaremore reflective of genetic perturbations than
individual molecular phenotypes; (2) VCMs exhibit a genetically
defined structure with few causal effects driving downstream
molecular cascades; or (3) VCMs constitute more accurate
phenotype estimates, since the correlation structure represented
as a PC is devoid of experimental and environmental noise inde-
pendent of which molecular phenotype is used.
To explore these possibilities, we contrasted the association
strength of the same vcmQTL variant with VCM states and
individual molecular events (Figure 6C). We further used the mo-
lecular association structure that defines VCMs to obtain a hier-1046 Cell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc.archy of molecular interactions: (1) entry phenotypes that exhibit
the strongest association with vcmQTLs, (2) direct (first-degree)
molecular phenotypes that are defined as being directly associ-
ated with the entry phenotype, and (3) indirect (second-degree)
molecular interactions that are associated with the entry pheno-
type via intermediate molecular associations. These analyses
revealed that VCM entry phenotypes exhibit a similar associa-
tion strength with vcmQTL variants as VCMs themselves, further
supporting our observation that a single molecular phenotype
can act as a seed for collateral changes within the respective
VCM (Figure 6C, black boxplot). Interestingly, simulations
demonstrated that PU.1 is most likely to act as an entry pheno-
type among our probedmolecular marks (Figure S6I). Consistent
with a hierarchical view, we observed that the remaining molec-
ular phenotypes are, on average, more weakly associated with
vcmQTL variants than the overall VCM state and VCM entry
phenotypes (Figure 6C, blue and orange boxplots). More specif-
ically, first-degree (direct) molecular phenotypes were more
strongly associated with vcmQTL variants than second-degree
(indirect) phenotypes.
We subsequently studied genetic variants that affect chro-
matin modules (vcmQTLs) and gene expression (eQTL) to obtain
a global view of the cis-regulatory information flow. Bayesian
modeling indicates that genetic variants affected gene expres-
sion levels through modulation of chromatin activity in 78% of
the cases (Figure 6D), thus illustrating that genetic perturbation
of chromatin states at cis-regulatory elements is, in most cases,
causal to changes in gene expression.
Finally, we found that all types of cQTLs are enriched in known
complex disease susceptibility variants, especially in immune
system disease variants (Figure 6E), providing direct functional
genetic evidence that non-coding disease susceptibility variants
exert their effects through perturbation of gene regulatory
elements.
DISCUSSION
Our analyses uncovered extensive coordination in chromatin
variation at and between cis-regulatory elements in a human
population, revealing the existence of genomic compartments
in the form of variable chromatin modules (VCMs). VCMs sug-
gest a higher-order modular organization of gene regulation in
the human genome, which is supported by the observation
that VCMs are strongly enriched within chromosomal contact
domains (Rao et al., 2014). Interestingly, immunity-related genes
are specifically associated with VCMs, consistent with the bio-
logical nature of LCLs. This finding implies that the resolution
of topologically associated domains (TADs) that were so far de-
tected (de Laat and Duboule, 2013; Dixon et al., 2012; Rao et al.,
2014) may extend to the level of individual genes (or sets of
co-regulated genes), consistent with the observation of micro-
topologies at the sub-Mb scale around key developmental genes
in mouse embryonic stem cells (Phillips-Cremins et al., 2013).
Our data further suggest that population-level chromatin pro-
filing might be an efficient strategy to assess putative chromatin
interactions at high spatial resolution, complementing other
molecular techniques aimed at mapping chromatin interactions
(Sanyal et al., 2012), transcription-coupled chromatin remod-
eling events (Smolle and Workman, 2013), TF-DNA-binding-
induced spreading of histone marks (Hathaway et al., 2012),
and enhancer/promoter-gene interactions, respectively.
VCMs also provide a rational framework for explaining why
regulatory events can vary independent of proximal sequence
changes in molecular terms (Kasowski et al., 2010, 2013; Kilpi-
nen et al., 2013; McVicker et al., 2013; Reddy et al., 2012; Villar
et al., 2014). Chromatin activity at cis-regulatory elements can be
influenced by distally acting genetic variants of variable effect
size, as we strongly suggest in this study for all analyzed molec-
ular phenotypes. In addition, we found that the activity level ofeach VCM can be captured by a single quantitative phenotype,
which suggests that molecular processes within each VCM
(i.e., histone-mark deposition and TF-DNA binding) are subject
to highly penetrant causal events. Our study provides strong
support for the hypothesis that these events correspond in large
part to genetic perturbations of TF-DNA interactions. This is
based on the fact that vcmQTLs: (1) are strongly enriched within
TF-occupied regions, (2) simultaneously perturb several layers of
chromatin structure, and (3) are in the majority of cases causal to
the observed changes in gene expression. From this, a model
emerges in which the perturbation of a single or a few TF-DNA
interactions can act as a seed for coordinated, collateral regula-
tory changes within a respective VCM. We hypothesize that
these changes are in large part mediated by long-range TF-TF
cooperativity events, given our observation that specific pairs
of lineage-determining, signal-dependent, and architectural fac-
tors (Heinz et al., 2010; Ong and Corces, 2014; Zhou et al., 2015)
are significantly enriched at VCM elements.
Interestingly, whereas ‘‘promoter VCMs’’ correlated frequently
with gene expression, we found that only a few ‘‘enhancer
VCMs’’ were linked to nearby genes, and only one-quarter of
PU.1 or H3K4me1 QTLs were shared with eQTLs. This finding
may imply either: (1) that abundant enhancer variation is of
such small effect on target gene expression as to be undetect-
able given the sample size of this study or (2) that the affected
enhancers are primed to conditionally regulate gene expression
(for example, in response to specific stimuli) (Calo andWysocka,
2013; Shlyueva et al., 2014; Spitz and Furlong, 2012). Alterna-
tively, these sequences may be subject to spurious regulatory
activity, which would explain the findings that: (1) only a minority
of genetically variable TF-DNAbinding events result in differential
gene expression (this work), (2) a large portion of TF-DNAbinding
events have no functional consequence (Cusanovich et al., 2014;
Farnham, 2009), and (3) TF binding sites tend to experience
rapid turnover (Dermitzakis and Clark, 2002; Villar et al., 2015).
Another complementary interpretation involves the model of
dose-dependent gene activation in which several TF binding
sites in multiple elements cumulatively contribute to gene ex-
pression (Spivakov, 2014). Under this model, loss of TF-DNA
binding at one binding site would have little to no discernible
functional consequence as long as the other implicated TF bind-
ing sites remain intact. This would, in turn, be consistent with
our observation that VCMs involving multiple cis-regulatory ele-
ments were farmore likely to correlate with gene expression vari-
ation than VCMs involving only one element.
Our present work on the discovery of molecular associations
and cQTLs for key chromatin organization components in a hu-
man population sample provides unique insights and a novel
framework for studying the molecular mechanisms underlying
variable transcriptional programs between individuals.
EXPERIMENTAL PROCEDURES
Study Samples
ChIP-seq and RNA-seq data were produced from lymphoblastoid cell lines
(LCLs) of 54 samples (Abecasis et al., 2010). All individuals were of European
origin (Utah residents with ancestry from northern and western Europe
and abbreviated as CEU). After excluding samples due to suspected
swaps, contamination (see Supplemental Experimental Procedures, 3.4), orCell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc. 1047
incomplete data availability (sample failed for a subset of assays), our final data
set consisted of 47 individuals for all ChIP assays and 46 individuals for gene
expression measurements (Table S1 for basic sample information).
ChIP-Seq and mRNA-Seq Experiments
All sequencing assays (ChIP and mRNA) were produced from a single growth
of LCLs, and cell culture and cell fixation were performed as previously
described (Kilpinen et al., 2013). ChIPs for H3K27ac, H3K4me1, H3k4me3,
PU.1, and RNA polymerase II (RPB2) were performed as described in the
Supplemental Experimental Procedures, 1.1–1.3. RNA extraction was done
following the procedure described in the Supplemental Experimental Proce-
dures, 2.1. Library preparation and sequencing done for ChIP and mRNA
are described in detail in Supplemental Experimental Procedures, 1.4 and
2.2, respectively. Short-read alignment for ChIP-seq and RNA-seq was per-
formed using BWA 0.5.9 (Li and Durbin, 2009) against the hg19 build of the
human reference genome supplemented with the Epstein-Barr virus (EBV)
sequence. All sequencing data management was done using Samtools (Li
et al., 2009) (Supplemental Experimental Procedures, 1.5 and 2.3). A summary
of mapping statistics is provided in Table S1B.
From ChIP-Seq Experiments to Molecular Phenotypes
ChIP-seq peak calling was not directly performed in the current set of samples
to avoid the issue of fuzzy peak boundaries. Instead, we used an indepen-
dently derived peak set for each assay that is based on six 1000 Genomes
Project Pilot individuals (Kilpinen et al., 2013). Quantifications for all peak-sam-
ple pairs were obtained by counting overlapping reads using HOMER (Heinz
et al., 2010), which resulted in a quantification matrix of size #samples 3
#peaks per assay (Supplemental Experimental Procedures, 1.6). Peak quanti-
fications were scaled to adjust for differences in total library size and were
corrected for batch effects using PEER (Stegle et al., 2010). We empirically
determined the optimal number of K PEER factors to be removed by finding
the K leading to the highest number of discovered QTLs (Supplemental Exper-
imental Procedures, 1.7).
From mRNA-Seq Experiments to Molecular Phenotypes
mRNA-seq data were quantified per sample based on GENCODE v15 (08/
2012) gene annotations (Harrow et al., 2012), resulting in a quantification
matrix of size #samples 3 #genes. All genes with five samples (>10%) or
more without any overlapping reads were removed, and the remaining quan-
tifications were scaled (10 M reads) and corrected for batch effects (PEER
K = 15) (Supplemental Experimental Procedures, 2.4 and 2.5).
Genotype Information
Genotypes for the 47 samples were obtained from two sources: (1) 34 with
genome-wide sequence data from 1000 Genomes Phase 1 v.3 and (2) 13
other CEU samples with Illumina Omni2.5 genotype data. Both were merged
by imputing untyped sequence variants into Illumina Omni2.5 data using
IMPUTE2 (Howie et al., 2009). Subsequently, all variants with minor allele fre-
quency below 5% were removed. See Lappalainen et al. (2013) for additional
details on genotype processing.
Analytical Methods for Molecular Phenotype-Phenotype
Associations
Mapping Molecular Associations
To map associations between pairs of peaks, we proceeded as follows for
each of the 15 possible unordered pairs of distinct molecular phenotypes:
we measured the inter-individual Pearson correlation and its significance
(p value) between quantifications of every possible pair of peaks within 1 Mb
distance of each other. Then, we corrected for multiple testing by controlling
for a 0.1% false discovery rate using the R/qvalue package (Alan Dabney,
John D. Storey and with assistance from Gregory R. Warnes. qvalue: Q-value
estimation for false discovery rate control. R package version 1.36.0.). Per-
centages (i.e., p1 estimates) of truly associated pairs were also estimated as
a byproduct (Supplemental Experimental Procedures, 3.1).
Building VCMs
We used graph theory to build VCMs and assumed that peaks are nodes and
significant peak associations edges. Any two peaks belong to the same VCM1048 Cell 162, 1039–1050, August 27, 2015 ª2015 Elsevier Inc.as soon as there is a path (i.e., a sequence of edges) that links them together;
otherwise, they belong to two distinct VCMs. Based on this, we implemented
an iterative algorithm that assigns peaks to VCMs. Then, VCM state activity
levels were obtained using principal component analysis (PCA) on quantifica-
tions of all peaks that belong to a VCM (Supplemental Experimental Proce-
dures, 3.2).
Functional Annotation of VCMs
We used the online service GREAT v2.0.2 to predict over-represented path-
ways and biological processes for VCM domains. Functional annotation
of VCM-associated genes was performed using the online serviceConsensus-
PathDB-human using the over-representation analysis module and gene
ontology categories (BP level 2) (Supplemental Experimental Procedures, 3.9).
Enrichment in Contact Domains
We used high-resolution chromosomal contact domains for LCLs from Rao
et al. (2014) to estimate how more likely associated peak pairs occur within
the same contact domain as compared to non-associated ones. To do so,
we used logistic regression with within/between contact domains as the binary
response, the association status (significant or not) as explanatory variable,
and the peak-to-peak distance as a covariate (Supplemental Experimental
Procedures, 3.11).
TFs Co-Occurrence at VCM Elements
We used the Fisher’s exact test to estimate enrichments of ENCODE TF-TF
pairs at non-overlapping VCM elements (Supplemental Experimental Proce-
dures, 3.13).
Analytical Methods for Quantitative Trait Loci
Mapping QTLs
We mapped cis-acting quantitative trait loci (QTLs) by performing linear re-
gressions between peak or gene quantifications and genotypes at all variant
sites within 250 kb (cis-window around the gene TSS or the peak center).
Then, we stored the best association for each peak/gene as a putative QTL
and corrected: (1) for multiple variants and (2) multiple peaks/genes being
tested genome-wide. We used permutations and false discovery rate to cor-
rect for (1) and (2), respectively. In addition, we repeated this analysis multiple
timeswith various cis-window sizes in order to determine the size providing the
best trade-off between discovery power and distal effect capture (Figures
S4A–S4C and Supplemental Experimental Procedures, 3.3). This analysis
has been performed using the software package FastQTL (http://fastqtl.
sourceforge.net/).
Estimating Proportion of Shared QTLs
To see if a QTL for assay A1 is replicated in assay A2, we first found a A2 peak
that matches the A1 peak by minimizing the distance between both, and then
we looked at the nominal p value of association between the QTL and the
matched A2 peak. By repeating this for all A1 QTLs, we can then estimate
the proportion that is shared with A2 using the p1 statistic (Supplemental
Experimental Procedures, 3.5).
Detecting Multiple Effects of QTLs
To map out the peaks affected by a QTL, we measured association between
the QTL and all features across all assays located within 250 kb and then
divided the resulting p values by the number of tested features (Bonferroni
correction) and finally reported as hits associations with a p value below the
0.05 threshold (Supplemental Experimental Procedures, 3.6).
Enrichment of QTLs within Functional Annotations
To measure how much more likely than by chance a set of QTLs is located
within a particular annotation, we developed an approach that corrects for
the fact that QTLs and annotations are not uniformly distributed along the
genome, with the goal of getting more robust enrichment estimates. This
method basically aims to find a null set of QTLs with some properties (e.g., dis-
tance to associated peak/gene) that match the original set (Supplemental
Experimental Procedures, 3.7).
Enrichment of QTLs with GWAS Hits
To measure how the QTL sets are enriched for GWAS hits, we used the NHGRI
GWAS Catalog (December 8, 2014), generated 1,000 null sets of QTLs with
matching properties (distance to associated peak/gene and minor allele fre-
quency), and tested how often these null QTL sets overlap GWAS hits as
compared to the original QTL set. Note that two variants are assumed to overlap
as soon as they are in high LD (Supplemental Experimental Procedures, 3.10).
QTL Causality Modeling
When a QTL is associated with two peaks (or genes), we inferred the most
likely signal transmission path (i.e., the causal chain of events) through the
two affected molecular phenotypes using Bayesian network modeling: we
enumerate the three possible models (QTL = > A1 = > A2, QTL = > A2 = >
A1 and QTL = > A1/QTL = > A2), estimate their respective likelihood, and
assign the most likely model to each triplet (Supplemental Experimental Pro-
cedures, 3.8).
Analytical Methods for Allele-Specific Effects
Mapping ASE
This was only performed on samples with sequence data (n = 34/47, Experi-
mental Procedures, ‘‘Genotype Information’’) at heterozygous SNPs. Devia-
tion from equilibrium (i.e., 50%–50%) was characterized using binomial tests,
accounting for multiple major sources of technical bias, such as reference
allele mapping bias, clonal reads, and non-unique mappability of reads, as
described previously (Kilpinen et al., 2013; Lappalainen et al., 2013; Waszak
et al., 2014) (Supplemental Experimental Procedures, 3.4). Allele-specific
effects (ASE) analysis was also used as a quality control step to identify puta-
tive sample swaps or contaminations.
Haplotypic ASE Coordination
We looked at ASEmeasured at phased heterozygous SNPs falling within VCM
peaks and assessed whether the signal was consistent with the haplotype
phase. In practice, we use logistic regression with concordance in allelic direc-
tion as response variable, association status (VCM/null) as explanatory vari-
able, and distance between peaks as covariates (Supplemental Experimental
Procedures, 3.12).
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